ArticleJournal of clinical and experimental hematopathology : JCEH2023

Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma.

Yasunobu Sekiguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.